13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-10-16 Event 2026-10-12 SEC 0001493152-26-047321 →

Choo Chee Kong → CytoMed Therapeutics Ltd GDTC

Stake: — Shares: 3,003,996 Class: Ordinary Shares

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
2 transactions
2 buys · 0 sales · 0 awards/exercises
Issuer Cluster
3 13D/G filings on this issuer
2 other filings besides this one
Filer Track Record
3 filings by this filer
2 other filings in the data moat
Short Interest · settle 2026-09-30
DTC 1.07
17,102 shares short · +372.4% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-07-20 Choo Chee Kong director, 10%+ owner Buy 100,000 $1.50 $150K
2026-07-14 Choo Chee Kong director, 10%+ owner Buy 100,000 $1.50 $150K

Other 13D/G Filings on CytoMed Therapeutics Ltd

FiledFormFilerStakeShares
2026-10-13 SCHEDULE 13D/A Choo Chee Kong 24.92% 2,974,746 view →
2026-07-24 SCHEDULE 13D/A Choo Chee Kong 24.30% 2,899,746 view →

Other Filings by Choo Chee Kong

FiledFormIssuerStakeShares
2026-10-13 SCHEDULE 13D/A CytoMed Therapeutics Ltd 24.92% 2,974,746 view →
2026-07-24 SCHEDULE 13D/A CytoMed Therapeutics Ltd 24.30% 2,899,746 view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →